Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical and Safety Outcomes Associated With Conversion From Brand-Name to Generic Tacrolimus Products in High Risk Transplant Recipients

NCT02014103 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT02014103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02014103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical and Safety Outcomes Associated With Conversion From Brand-Name to Generic Tacrolimus Products in High Risk Transplant Recipients
Lead sponsor
University of Cincinnati
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
August 31, 2015
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication of transplant